Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT04303013
  4. Details
NCT04303013 Clinical Trial

Guided Meditation During Radiotherapy.

Cancer Clinical Trial

Official title:
A Randomized Controlled Trial of Guided Mindfulness Intervention During Radiotherapy.

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04303013
Other study ID # 18-004546
Secondary ID NCI-2021-02757
Status Completed
Phase Phase 3
First received
Last updated
Start date June 1, 2019
Est. completion date March 27, 2023

Study information
Verified date August 2023
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research is to gather information on the effects of Mindfulness-Based Intervention (MBI) on quality of life during and after radiation treatment. This study involves randomization. There is a 50 percent chance (like a flip of the coin) that you will be randomized to attend meditation sessions during treatment.

Recruitment information / eligibility
Status Completed
Enrollment 75
Est. completion date March 27, 2023
Est. primary completion date March 27, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years - Prescribed a course of at least 15 daily fractions of RT for curative intent of any malignancy - Willing to attend MBI sessions weekly during RT - Able to transport themselves to scheduled MBI sessions in the DAHLC - Able to complete questionnaire(s) by themselves - Native English speaker (MBI sessions, videos, and QOL questionnaires are only available in English) - ECOG Performance Status 0-2 Exclusion Criteria: - Prescribed a course of RT with fewer than 15 consecutive, daily fractions - Unable or unwilling to attend required MBI sessions

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Meditation
Patients will attend weekly in person guided meditation sessions during the course of their radiation treatment. Patient will complete quality of life surveys before, during and after treatment.
Other:
• Standard of Care
Patient not assigned to meditation will undergo radiation with usual care and complete quality of life surveys before, during and after treatment.

Locations
Country Name City State
United States Mayo Clinic in Rochester Rochester Minnesota

Sponsors (1)
Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Effectiveness of Meditation Sessions including emotional, physical, functional, and social domains assessed via the FACT-G during and after radiotherapy for the treatment of cancer. Before radiation treatment.
Primary Effectiveness of Meditation Sessions Comparison of change in total LASA-6 and single question relaxation surveys. During radiation treatment
Primary Effectiveness of Meditation Sessions Comparison of change in FACT-G, Promis 10 and LASA-6 surveys. 3 months and 12 months post radiation treatment.
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases